In the long run, they save money by avoiding the morbidity of diseases that could and should be prevented altogether. If screening tests and preventive services continue to be devalued, we will all pay the price. References US Preventive Services Task Force. Statement from the National Cancer Institute on the National Advisory Board Recommendations on Mammography. Ten-year risk of false positive screening mammograms and clinical breast examinations.
Black women receive less mammography even with similar use of primary care.
Factors associated with screening mammography in low-income women. Dr Fleischman is assistant professor of medicine and co-director of the Center for Women's Health, Allegheny University of the Health Sciences, Philadelphia. Your comments on the subject of this editorial are welcome and may be published in Editor's Mailbox. The McGraw-Hill Companies.